Video
Holger Lenz discusses the interest of Bayer in the microbiome space during Microbiome Connect: Europe 2022.
Maria Teresa Abreu (University of Miami, USA) discussed some new strategies to design clinical trials.
Theresa Pizarro, (Case Western Reserve University School of Medicine) discussed the roles of epithelial barrier’s cytokines, gut microbiome and Gasdermin in IBD patients.
Sudarshen Paramsothy (University of New South Wales, Australia) discussed the controversials about FMT in IBD patients.
Herbert Tilg (University Innsbruck, Austria) discussed the relationship between Inflammatory Bowel Diseases and gut microbiome.
Patrice Cani (Université catholique de Louvain) discusses the role of Akkermansia muciniphila in the gut barrier.
Philippe Lagella of the Instituit National de la Rcherche Agronomique - France, talks about the increasing interest in Faecalibacterium prausnitzii and its possible use.
Dr. Raanan Shamir discusses the role that the intestinal microbiota plays in the development of celiac disease.
New criteria for the probiotics of the future. We discussed it with Lorenzo Morelli (Catholic University of the Sacred Heart, Italy).
François Bourdichon presents the IDF's initiative of defining standards and putting a frame beyond probiotics.
